I help bioethics and AI governance teams in pharma, life sciences, and research institutions turn principles into the products patients, clinicians, and researchers actually use. Fluent in product, fluent in policy, embedded fully in neither.
Expert trainings that help your team recognize where a principle has to become an interface decision, and how to specify that clearly enough for design and engineering to build it.
Ongoing, hands-on product and UX leadership embedded with your team, building a culture where principles reliably make it all the way to the interfaces patients, clinicians, and researchers use, not stopping at a requirements doc.
A short, structured sprint to define how ethics and governance decisions get made in your organization, and who owns them, before ad hoc precedent hardens into policy.
I share ranges in our first conversation, and I never want budget to be the reason the right work does not happen. If the mission is right, let us find a shape that works.
Fifteen years of digital strategy and software design in healthcare and life sciences, much of it leading user experience research and design at NIH's All of Us Research Program, where from 2019 to 2025 I supported the program from launching the Researcher Workbench through migrating 700,000+ consented participants to a new platform.
I spent years moving product decisions through institutional review and research ethics boards before joining Harvard Medical School's Center for Bioethics as a 2024–2025 Fellow. I also keep a foot in the research world, publishing, speaking, and pursuing fellowships on the ethics of technology, so the thinking behind the work stays current and tested.
Both and Neither takes its name from that pairing. Fluent in product, fluent in policy, embedded fully in neither.
Both and Neither is currently open to new clients. If you think I can help, or you just want to talk about the work, please reach out. I love talking with other product and UX leaders working on shared problems.
Subscribe for occasional notes and updates.
Unsubscribe at any time.